Edward Burgess

Title: Edward Burgess - Innovator in Pharmaceutical Compounds

Introduction

Edward Burgess is an innovative inventor based in Marietta, Georgia, known for his contributions to the field of pharmaceutical sciences. With a focus on aroylaniline compounds that exhibit anti-retroviral activity, his work has significant implications for treating retroviral infections.

Latest Patents

Burgess holds a patent for "Aroylaniline Compounds, Pharmaceutical Compositions, and Methods of." This patent specifically details the development of aroylaniline compounds that display anti-retroviral properties, creating pharmaceutical compositions that can effectively treat retroviral infections by administering an antiviral effective amount of these compounds to infected hosts.

Career Highlights

Throughout his career, Edward Burgess has worked with notable organizations, including the United States of America as represented by the Department of Health and Georgia Tech Research Corporation. His work in these institutions has been crucial in the advancement of research related to pharmaceutical innovation.

Collaborations

Burgess collaborated with talented professionals in his field, including Rudiger D Haugwitz and Leon H Zalkow. These partnerships have contributed to the development and refinement of his innovative approaches in the realm of pharmaceutical compounds.

Conclusion

In conclusion, Edward Burgess is a noteworthy inventor whose work has made significant strides in pharmaceutical innovation, particularly in the fight against retroviral infections. His patent highlights his dedication to advancing scientific research and underscores the potential impact of his inventions in healthcare.